AFP — AFT Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- AU$310.68m
- AU$342.61m
- NZ$156.64m
- 87
- 22
- 42
- 51
Annual balance sheet for AFT Pharmaceuticals, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 6.92 | 6.12 | 3.21 | 7.94 | 4.75 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 16.3 | 22.6 | 29.2 | 29.9 | 39.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 51.3 | 55.3 | 67.9 | 77.5 | 94.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.357 | 4.03 | 3.79 | 3.36 | 3.37 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 63.6 | 87.1 | 105 | 127 | 148 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 58.5 | 25.1 | 32.1 | 29.1 | 39.8 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 58.5 | 69.8 | 68.5 | 65 | 74.8 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 5.09 | 17.3 | 36.6 | 62.3 | 73.3 |
| Total Liabilities & Shareholders' Equity | 63.6 | 87.1 | 105 | 127 | 148 |
| Total Common Shares Outstanding |